Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Provista Diagnostics, Inc
ClinicalTrials.gov Identifier:
NCT02078570
First received: February 28, 2014
Last updated: November 3, 2015
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)